ATA309588A - Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform - Google Patents

Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform

Info

Publication number: ATA309588A
Authority: AT; Austria
Prior art keywords: crystal shape; ciclosporin; new; production; pharmaceutical composition
Prior art date: 1987-12-21

Application number

AT0309588A

Other languages

English (en)

Other versions

AT403163B (de

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-21

Filing date

1988-12-20

Publication date

1997-04-15

1988-12-20 Application filed by Sandoz Ag filed Critical Sandoz Ag

1997-04-15 Publication of ATA309588A publication Critical patent/ATA309588A/de

1997-11-25 Application granted granted Critical

1997-11-25 Publication of AT403163B publication Critical patent/AT403163B/de

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
108010036949 Cyclosporine Proteins 0.000 title 1
229960001265 ciclosporin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT0309588A 1987-12-21 1988-12-20 Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform AT403163B (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US13623087A	1987-12-21	1987-12-21
US17261388A	1988-03-24	1988-03-24
US21254888A	1988-06-28	1988-06-28

Publications (2)

Publication Number	Publication Date
ATA309588A true ATA309588A (de)	1997-04-15
AT403163B AT403163B (de)	1997-11-25

Family

ID=27384838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0309588A AT403163B (de)	1987-12-21	1988-12-20	Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform

Country Status (27)

Country	Link
JP (1)	JPH0791316B2 (de)
KR (1)	KR100188305B1 (de)
AT (1)	AT403163B (de)
AU (1)	AU626274B2 (de)
BE (1)	BE1002665A4 (de)
CA (1)	CA1341396C (de)
CH (1)	CH677926A5 (de)
CY (1)	CY1799A (de)
DE (1)	DE3843054C2 (de)
DK (1)	DK175220B1 (de)
ES (1)	ES2012580A6 (de)
FI (1)	FI89065C (de)
FR (1)	FR2624863B1 (de)
GB (1)	GB2211848B (de)
GR (1)	GR1002486B (de)
HK (1)	HK102894A (de)
HU (1)	HU203564B (de)
IE (1)	IE62006B1 (de)
IL (1)	IL88719A0 (de)
IT (1)	IT1235356B (de)
LU (1)	LU87409A1 (de)
MY (1)	MY103943A (de)
NL (1)	NL195096C (de)
NO (1)	NO177228C (de)
NZ (1)	NZ227384A (de)
SE (1)	SE503174C2 (de)
SG (1)	SG99494G (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639724A (en)	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
US6007840A (en) *	1988-09-16	1999-12-28	Novartis Ag	Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) *	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물
US7081445B2 (en)	1989-02-20	2006-07-25	Novartis Ag	Cyclosporin galenic forms
US5294604A (en) *	1989-12-20	1994-03-15	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) *	1991-03-18	1991-05-01	Sandoz Ltd	Improvements in or relating to organic compounds
US6262022B1 (en)	1992-06-25	2001-07-17	Novartis Ag	Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) *	1992-05-13	1998-01-16	Sandoz Ltd	Ophthalmic compositions
DK0589843T3 (da)	1992-09-25	2002-04-02	Novartis Ag	Cyclosporinholdige farmaceutiske præparater
JP3833248B2 (ja)	1994-11-03	2006-10-11	ノバルティス・アクチエンゲゼルシャフト	簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US5962019A (en) *	1995-08-25	1999-10-05	Sangstat Medical Corporation	Oral cyclosporin formulations
US5766629A (en)	1995-08-25	1998-06-16	Sangstat Medical Corporation	Oral cyclosporin formulations
DE19544507B4 (de)	1995-11-29	2007-11-15	Novartis Ag	Cyclosporin enthaltende Präparate
US6262054B1 (en)	1996-02-01	2001-07-17	Sloan-Kettering Institute Of Cancer Research	Combination therapy method for treating breast cancer using edatrexate
AU737053B2 (en)	1997-01-30	2001-08-09	Novartis Ag	Oil-free pharmaceutical compositions containing cyclosporin A
TW581681B (en)	1998-02-20	2004-04-01	Nektar Therapeutics	Liquid crystal forms of cyclosporin
US7732404B2 (en)	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
CA2553381C (en)	2004-01-20	2011-03-22	Allergan, Inc.	Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (zh) *	2005-10-11	2010-04-21	山东新时代药业有限公司	高纯度环孢菌素a的制备方法
MY180581A (en)	2011-05-27	2020-12-02	Allergan Inc	A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
CN104080442B (zh) *	2011-11-15	2018-01-05	阿勒根公司	环孢菌素a形式2的悬浮液
AU2012339701B8 (en) *	2011-11-15	2017-11-16	Allergan, Inc.	Autoclavable suspensions of cyclosporin A Form 2
RU2639393C2 (ru)	2011-11-15	2017-12-21	Аллерган, Инк.	Состав пролонгированного действия циклоспорина формы 2
EP2780358B1 (de) *	2011-11-15	2016-03-23	Allergan, Inc.	Cyclosporin-2 im form 2 und verfahren zu deren herstellung
TW202430537A (zh) *	2022-10-20	2024-08-01	日商中外製藥股份有限公司	環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH614931A5 (de) *	1975-11-04	1979-12-28	Sandoz Ag
CH640519A5 (en) *	1976-04-09	1984-01-13	Sandoz Ag	Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) *	1976-04-09	1978-09-26	Sandoz Ltd.	Organic compounds
DE2819094A1 (de) *	1977-05-10	1978-11-23	Sandoz Ag	Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) *	1978-10-18	1983-07-15	Sandoz Ag	Antibiotic, its preparation and use

1988
- 1988-12-09 HU HU886374A patent/HU203564B/hu unknown
- 1988-12-19 NZ NZ227384A patent/NZ227384A/xx unknown
- 1988-12-19 GB GB8829556A patent/GB2211848B/en not_active Expired - Lifetime
- 1988-12-19 IL IL88719A patent/IL88719A0/xx unknown
- 1988-12-19 DK DK198807054A patent/DK175220B1/da not_active IP Right Cessation
- 1988-12-19 FR FR888816886A patent/FR2624863B1/fr not_active Expired - Lifetime
- 1988-12-19 SE SE8804570A patent/SE503174C2/sv not_active IP Right Cessation
- 1988-12-19 AU AU27055/88A patent/AU626274B2/en not_active Expired
- 1988-12-19 NO NO885625A patent/NO177228C/no unknown
- 1988-12-19 CH CH4687/88A patent/CH677926A5/de not_active IP Right Cessation
- 1988-12-19 IE IE377988A patent/IE62006B1/en not_active IP Right Cessation
- 1988-12-19 FI FI885869A patent/FI89065C/fi not_active IP Right Cessation
- 1988-12-20 IT IT8848690A patent/IT1235356B/it active
- 1988-12-20 LU LU87409A patent/LU87409A1/fr unknown
- 1988-12-20 BE BE8801421A patent/BE1002665A4/fr not_active IP Right Cessation
- 1988-12-20 KR KR1019880017194A patent/KR100188305B1/ko not_active Expired - Lifetime
- 1988-12-20 AT AT0309588A patent/AT403163B/de not_active IP Right Cessation
- 1988-12-20 GR GR880100850A patent/GR1002486B/el not_active IP Right Cessation
- 1988-12-20 JP JP63321857A patent/JPH0791316B2/ja not_active Expired - Lifetime
- 1988-12-21 NL NL8803125A patent/NL195096C/nl active Search and Examination
- 1988-12-21 DE DE3843054A patent/DE3843054C2/de not_active Expired - Lifetime
- 1988-12-21 MY MYPI88001495A patent/MY103943A/en unknown
- 1988-12-21 CA CA000586611A patent/CA1341396C/en not_active Expired - Fee Related
- 1988-12-21 ES ES8803887A patent/ES2012580A6/es not_active Expired - Lifetime
1994
- 1994-07-21 SG SG99494A patent/SG99494G/en unknown
- 1994-09-22 HK HK102894A patent/HK102894A/xx not_active IP Right Cessation
1995
- 1995-02-17 CY CY179995A patent/CY1799A/en unknown

Also Published As

Publication number	Publication date
AT403163B (de)	1997-11-25
KR100188305B1 (ko)	1999-06-01
FI89065C (fi)	1993-09-30
FI885869L (fi)	1989-06-22
FI89065B (fi)	1993-04-30
MY103943A (en)	1993-10-30
GB8829556D0 (en)	1989-02-08
IT8848690A0 (it)	1988-12-20
DK705488D0 (da)	1988-12-19
SG99494G (en)	1994-10-28
IE62006B1 (en)	1994-12-14
DE3843054C2 (de)	2003-08-21
CY1799A (en)	1995-02-17
HK102894A (en)	1994-09-30
BE1002665A4 (fr)	1991-04-30
KR890009975A (ko)	1989-08-05
ES2012580A6 (es)	1990-04-01
NZ227384A (en)	1991-09-25
CA1341396C (en)	2002-11-05
SE8804570D0 (sv)	1988-12-19
IL88719A0 (en)	1989-07-31
JPH01211598A (ja)	1989-08-24
GR1002486B (el)	1996-12-09
DK175220B1 (da)	2004-07-12
SE503174C2 (sv)	1996-04-15
CH677926A5 (de)	1991-07-15
GB2211848B (en)	1991-11-06
JPH0791316B2 (ja)	1995-10-04
GR880100850A (el)	1994-03-31
AU2705588A (en)	1989-06-22
FR2624863B1 (fr)	1991-04-26
FI885869A0 (fi)	1988-12-19
DE3843054A1 (de)	1989-07-27
NO885625D0 (no)	1988-12-19
AU626274B2 (en)	1992-07-30
NL8803125A (nl)	1989-07-17
LU87409A1 (fr)	1989-07-07
DK705488A (da)	1989-06-22
FR2624863A1 (fr)	1989-06-23
NL195096C (nl)	2004-02-09
IE883779L (en)	1989-06-21
HU203564B (en)	1991-08-28
HUT49893A (en)	1989-11-28
NO885625L (no)	1989-06-22
SE8804570L (sv)	1989-06-22
NO177228C (no)	1995-08-09
GB2211848A (en)	1989-07-12
IT1235356B (it)	1992-06-30
NO177228B (no)	1995-05-02

Similar Documents

Publication	Publication Date	Title
ATA309588A (de)	1997-04-15	Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform
DE3780226D1 (de)	1992-08-13	Neue pharmazeutische praeparate zur topischen applikation, verfahren zu ihrer herstellung und ihre verwendung.
PT82169A (de)	1986-04-01	Neue sulfonylaminoathylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT82789B (de)	1988-05-17	Neue 2-arylmidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT80476B (de)	1987-04-13	Neue aminotetralinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69033534D1 (de)	2000-06-08	Xylit enthaltende hartbonbons und verfahren zu ihrer herstellung
ATA195788A (de)	1996-05-15	Tripeptide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE58907887D1 (de)	1994-07-21	Kohlensäureester von Polysacchariden und Verfahren zu ihrer Herstellung.
DE3887390D1 (de)	1994-03-10	Lichtschutz-Schirmstruktur und Verfahren zu ihrer Herstellung.
DE68909412D1 (de)	1993-10-28	Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE68927949D1 (de)	1997-05-15	3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
ATA69888A (de)	1994-09-15	Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten
ATE143010T1 (de)	1996-10-15	Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE68922538D1 (de)	1995-06-14	Fäserchen enthaltender Streifen und Verfahren zu dessen Herstellung.
DE3674582D1 (de)	1990-10-31	(s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE3852963D1 (de)	1995-03-23	Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung.
DE3886856D1 (de)	1994-02-17	Hitzebeständige Materialien und Verfahren zu ihrer Herstellung.
DE3887068D1 (de)	1994-02-24	2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
PT74129A (de)	1982-01-01	3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide verfahren zu ihrer herstellung ihre verwendung und sie enthaltende pharmazeutische zubereitungen
DE3670635D1 (de)	1990-05-31	Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE68915094D1 (de)	1994-06-09	Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen.
ATA267788A (de)	1992-11-15	Verfahren zur herstellung von polynucleotiden, so erhaltene produkte und diese enthaltende pharmazeutische zusammensetzungen
DE3682370D1 (de)	1991-12-12	3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817D1 (de)	1992-12-17	1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3773716D1 (de)	1991-11-21	Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.

Legal Events

Date	Code	Title	Description
1991-06-15	ELA	Expired due to lapse of time
2009-09-15	ELA	Expired due to lapse of time